MedTrace Logo

Magnetic Resonance & Optical Spectroscopy Validation

NCT01827527 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 31

Last updated 2026-04-17

No results posted yet for this study

Summary

The purpose of this study is to develop and refine techniques for using magnetic resonance and optical spectroscopy to investigate how your body uses energy.

Conditions

  • Validation Studies
  • Magnetic Resonance Spectroscopy

Sponsors & Collaborators

  • AdventHealth Translational Research Institute

    lead OTHER

Principal Investigators

  • Steven R. Smith, MD · Translational Research Institute for Metabolism and Diabetes

  • Heather Cornnell, PhD · Translational Research Institute for Metabolism and Diabetes

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2024-12-30
Completion
2024-12-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01827527 on ClinicalTrials.gov